Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Eargo5 launch appears to be on track, says Wells Fargo » 14:55
06/22/21
06/22
14:55
06/22/21
14:55
EAR

Eargo

$37.61 /

+0.47 (+1.27%)

Wells Fargo analyst…

Wells Fargo analyst Lawrence Biegelsen said he has fielded several questions from investors in recent weeks on the Eargo5 launch, which he notes is "the most significant launch in the company's history." His talks with the company suggest that the launch is on track and that they expect to begin shipments by the end of June, as previously communicated, said Biegelsen. He keeps an Overweight rating and $52 price target on Eargo shares.

ShowHide Related Items >><<
EAR Eargo
$37.61 /

+0.47 (+1.27%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
EAR Eargo
$37.61 /

+0.47 (+1.27%)

  • 16
    Oct
EAR Eargo
$37.61 /

+0.47 (+1.27%)

Over a week ago
Conference/Events
UBS to hold a virtual conference » 04:55
05/26/21
05/26
04:55
05/26/21
04:55
NBTX

Nanobiotix

$16.16 /

+ (+0.00%)

, MRNA

Moderna

$169.25 /

+5.16 (+3.14%)

, TELA

Tela Bio

$13.85 /

+0.6 (+4.53%)

, ICLR

Icon

$229.34 /

-2.74 (-1.18%)

, AMWL

Amwell

$11.89 /

+0.38 (+3.30%)

, BRKR

Bruker

$69.86 /

+0.12 (+0.17%)

, SIOX

Sio Gene Therapies

$2.22 /

+0.01 (+0.45%)

, BMRN

BioMarin

$77.60 /

+0.08 (+0.10%)

, NVS

Novartis

$88.51 /

+0.51 (+0.58%)

, TERN

Terns Pharmaceuticals

$15.39 /

-0.62 (-3.87%)

, EAR

Eargo

$32.10 /

-1.12 (-3.37%)

, JAZZ

Jazz Pharmaceuticals

$177.71 /

-1.17 (-0.65%)

, TNDM

TNDM

/

+

, BAYRY

Bayer

$16.93 /

-0.265 (-1.54%)

, ANIK

Anika Therapeutics

$43.66 /

-0.55 (-1.24%)

, CVAC

CureVac

$115.64 /

+1.27 (+1.11%)

, BSX

Boston Scientific

$43.03 /

+0.215 (+0.50%)

, APLT

Applied Therapeutics

$18.57 /

+1.06 (+6.05%)

, ARVN

Arvinas

$65.15 /

-0.78 (-1.18%)

, PACB

Pacific Biosciences

$25.68 /

-0.1 (-0.39%)

, ABBV

AbbVie

$114.56 /

-1.35 (-1.16%)

, ZYXI

Zynex

$14.12 /

-0.61 (-4.14%)

, BAX

Baxter

$82.34 /

-0.42 (-0.51%)

, KOD

Kodiak Sciences

$82.62 /

+1.66 (+2.05%)

, ARWR

Arrowhead

$73.96 /

-0.83 (-1.11%)

, CUTR

Cutera

$36.98 /

-1.15 (-3.02%)

, TVTY

Tivity Health

$25.73 /

-0.09 (-0.35%)

, PTCT

PTC Therapeutics

$39.66 /

+0.52 (+1.33%)

, CTLT

Catalent

$103.45 /

+0.88 (+0.86%)

, RHHBY

Roche

$43.57 /

+ (+0.00%)

, CLPT

ClearPoint Neuro

$18.07 /

-0.38 (-2.06%)

, BNTX

BioNTech

$197.53 /

+2.64 (+1.35%)

, ALGN

Align Technology

$594.91 /

-9.47 (-1.57%)

, DBTX

Decibel Therapeutics

$7.85 /

-0.205 (-2.55%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link

ShowHide Related Items >><<
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

TNDM TNDM
/

+

TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CUTR Cutera
$36.98 /

-1.15 (-3.02%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
MRNA Moderna
$169.25 /

+5.16 (+3.14%)

05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
ICLR Icon
$229.34 /

-2.74 (-1.18%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
AMWL Amwell
$11.89 /

+0.38 (+3.30%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
BRKR Bruker
$69.86 /

+0.12 (+0.17%)

05/06/21 BTIG
Bruker price target raised to $80 from $73 at BTIG
05/06/21 SVB Leerink
Bruker price target raised to $80 from $70 at SVB Leerink
02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

04/30/21 Wedbush
BioMarin's Q1 revenue was better than expected, says Wedbush
04/26/21 Credit Suisse
BioMarin assumed with an Outperform at Credit Suisse
03/04/21 Guggenheim
BioMarin assumed at Buy from Neutral at Guggenheim
03/01/21 Evercore ISI
BioMarin upgraded to Outperform from In Line at Evercore ISI
NVS Novartis
$88.51 /

+0.51 (+0.58%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
EAR Eargo
$32.10 /

-1.12 (-3.37%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
TNDM TNDM
/

+

05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Tandem Diabetes initiated with an Underweight at Barclays
05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
ANIK Anika Therapeutics
$43.66 /

-0.55 (-1.24%)

12/16/20 Barrington
Anika Therapeutics upgraded to Outperform with $43 target at Barrington
12/16/20 Barrington
Anika Therapeutics upgraded to Outperform from Market Perform at Barrington
CVAC CureVac
$115.64 /

+1.27 (+1.11%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley
Zynex downgraded to Neutral from Buy at B. Riley Securities
BAX Baxter
$82.34 /

-0.42 (-0.51%)

05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

05/11/21 Roth Capital
Roth Capital upgrades Kodiak Sciences to Buy on recent selloff
05/11/21 Roth Capital
Kodiak Sciences upgraded to Buy from Neutral at Roth Capital
05/11/21 BMO Capital
Kodiak Sciences price target lowered to $104 from $138 at BMO Capital
05/11/21 Barclays
Kodiak Sciences price target lowered to $86 from $90 at Barclays
ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

02/08/21 B. Riley
Arrowhead price target raised to $106 from $98 at B. Riley Securities
02/08/21 Citi
Arrowhead price target raised to $110 from $90 at Citi
02/05/21 Chardan
Arrowhead price target raised to $97 from $81 at Chardan
02/05/21 H.C. Wainwright
Arrowhead price target raised to $95 from $90 at H.C. Wainwright
CUTR Cutera
$36.98 /

-1.15 (-3.02%)

03/05/21 Piper Sandler
Cutera price target raised to $42 from $38 at Piper Sandler
02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform with $19 target at Credit Suisse
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform from Neutral at Credit Suisse
PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
CTLT Catalent
$103.45 /

+0.88 (+0.86%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
RHHBY Roche
$43.57 /

+ (+0.00%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

03/18/21 Lake Street
Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential
03/18/21 Lake Street
ClearPoint Neuro initiated with a Buy at Lake Street
02/22/21 B. Riley
ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities
01/22/21 B. Riley
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

04/29/21 SVB Leerink
Align Technology price target raised to $770 from $690 at SVB Leerink
04/29/21 Credit Suisse
Align Technology price target raised to $715 from $693 at Credit Suisse
04/29/21 Stifel
Align Technology price target raised to $750 from $650 at Stifel
04/29/21 Baird
Align Technology price target raised to $745 from $655 at Baird
DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

TNDM TNDM
/

+

TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

EAR Eargo
$32.10 /

-1.12 (-3.37%)

CUTR Cutera
$36.98 /

-1.15 (-3.02%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

  • 19
    Feb
  • 12
    Feb
  • 12
    Feb
  • 05
    Feb
  • 28
    Jan
  • 15
    Jan
  • 16
    Dec
  • 11
    Dec
  • 23
    Nov
  • 18
    Nov
  • 11
    Nov
  • 21
    Oct
  • 16
    Oct
  • 17
    Sep
  • 12
    Aug
  • 14
    Aug
  • 23
    Jul
  • 15
    Jul
  • 26
    Jun
  • 11
    Jun
RHHBY Roche
$43.57 /

+ (+0.00%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

EAR Eargo
$32.10 /

-1.12 (-3.37%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/25/21
05/25
04:55
05/25/21
04:55
NBTX

Nanobiotix

$16.16 /

+ (+0.00%)

, MRNA

Moderna

$164.12 /

+2.565 (+1.59%)

, TELA

Tela Bio

$13.25 /

-0.05 (-0.38%)

, ICLR

Icon

$232.11 /

+1.2 (+0.52%)

, AMWL

Amwell

$11.54 /

-0.16 (-1.37%)

, BRKR

Bruker

$69.74 /

+0.64 (+0.93%)

, SIOX

Sio Gene Therapies

$2.22 /

+0.015 (+0.68%)

, BMRN

BioMarin

$77.49 /

-0.63 (-0.81%)

, NVS

Novartis

$88.00 /

-0.065 (-0.07%)

, TERN

Terns Pharmaceuticals

$15.80 /

-0.11 (-0.69%)

, EAR

Eargo

$33.22 /

+1.17 (+3.65%)

, JAZZ

Jazz Pharmaceuticals

$178.88 /

-1.08 (-0.60%)

, TNDM

TNDM

/

+

, BAYRY

Bayer

$17.19 /

+0.16 (+0.94%)

, ANIK

Anika Therapeutics

$44.12 /

+0.11 (+0.25%)

, CVAC

CureVac

$114.37 /

-0.875 (-0.76%)

, BSX

Boston Scientific

$42.81 /

+0.705 (+1.67%)

, APLT

Applied Therapeutics

$17.51 /

+0.26 (+1.51%)

, ARVN

Arvinas

$65.93 /

-0.54 (-0.81%)

, PACB

Pacific Biosciences

$25.78 /

+0.2 (+0.78%)

, ABBV

AbbVie

$115.91 /

-0.2 (-0.17%)

, ZYXI

Zynex

$14.72 /

-0.08 (-0.54%)

, BAX

Baxter

$82.75 /

-0.31 (-0.37%)

, KOD

Kodiak Sciences

$81.22 /

+0.81 (+1.01%)

, ARWR

Arrowhead

$74.77 /

+0.64 (+0.86%)

, CUTR

Cutera

$38.15 /

-0.17 (-0.44%)

, TVTY

Tivity Health

$25.85 /

+0.63 (+2.50%)

, PTCT

PTC Therapeutics

$39.14 /

-0.34 (-0.86%)

, CTLT

Catalent

$102.55 /

+0.76 (+0.75%)

, RHHBY

Roche

$43.16 /

-0.09 (-0.21%)

, CLPT

ClearPoint Neuro

$18.37 /

-0.3 (-1.61%)

, BNTX

BioNTech

$194.87 /

-0.68 (-0.35%)

, ALGN

Align Technology

$604.00 /

+12.52 (+2.12%)

, DBTX

Decibel Therapeutics

$8.06 /

-0.175 (-2.13%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link

ShowHide Related Items >><<
ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

TVTY Tivity Health
$25.85 /

+0.63 (+2.50%)

TNDM TNDM
/

+

TERN Terns Pharmaceuticals
$15.80 /

-0.11 (-0.69%)

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

KOD Kodiak Sciences
$81.22 /

+0.81 (+1.01%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

DBTX Decibel Therapeutics
$8.06 /

-0.175 (-2.13%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CUTR Cutera
$38.15 /

-0.17 (-0.44%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BRKR Bruker
$69.74 /

+0.64 (+0.93%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
MRNA Moderna
$164.12 /

+2.565 (+1.59%)

05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
ICLR Icon
$232.11 /

+1.2 (+0.52%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
AMWL Amwell
$11.54 /

-0.16 (-1.37%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
BRKR Bruker
$69.74 /

+0.64 (+0.93%)

05/06/21 BTIG
Bruker price target raised to $80 from $73 at BTIG
05/06/21 SVB Leerink
Bruker price target raised to $80 from $70 at SVB Leerink
02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

04/30/21 Wedbush
BioMarin's Q1 revenue was better than expected, says Wedbush
04/26/21 Credit Suisse
BioMarin assumed with an Outperform at Credit Suisse
03/04/21 Guggenheim
BioMarin assumed at Buy from Neutral at Guggenheim
03/01/21 Evercore ISI
BioMarin upgraded to Outperform from In Line at Evercore ISI
NVS Novartis
$88.00 /

-0.065 (-0.07%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
TERN Terns Pharmaceuticals
$15.80 /

-0.11 (-0.69%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
EAR Eargo
$33.22 /

+1.17 (+3.65%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
TNDM TNDM
/

+

05/24/21 Barclays
Tandem Diabetes initiated with an Underweight at Barclays
05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
05/06/21 Piper Sandler
Tandem Diabetes remains a 'name to buy' after Q1 beat, says Piper Sandler
BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
ANIK Anika Therapeutics
$44.12 /

+0.11 (+0.25%)

12/16/20 Barrington
Anika Therapeutics upgraded to Outperform with $43 target at Barrington
12/16/20 Barrington
Anika Therapeutics upgraded to Outperform from Market Perform at Barrington
CVAC CureVac
$114.37 /

-0.875 (-0.76%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
04/29/21 Canaccord
Boston Scientific price target raised to $49 from $44 at Canaccord
APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley
Zynex downgraded to Neutral from Buy at B. Riley Securities
BAX Baxter
$82.75 /

-0.31 (-0.37%)

05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
03/26/21 JPMorgan
Baxter a 'stock to own' into earnings and beyond, says JPMorgan
KOD Kodiak Sciences
$81.22 /

+0.81 (+1.01%)

05/11/21 Roth Capital
Roth Capital upgrades Kodiak Sciences to Buy on recent selloff
05/11/21 Roth Capital
Kodiak Sciences upgraded to Buy from Neutral at Roth Capital
05/11/21 BMO Capital
Kodiak Sciences price target lowered to $104 from $138 at BMO Capital
05/11/21 Barclays
Kodiak Sciences price target lowered to $86 from $90 at Barclays
ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

02/08/21 B. Riley
Arrowhead price target raised to $106 from $98 at B. Riley Securities
02/08/21 Citi
Arrowhead price target raised to $110 from $90 at Citi
02/05/21 Chardan
Arrowhead price target raised to $97 from $81 at Chardan
02/05/21 H.C. Wainwright
Arrowhead price target raised to $95 from $90 at H.C. Wainwright
CUTR Cutera
$38.15 /

-0.17 (-0.44%)

03/05/21 Piper Sandler
Cutera price target raised to $42 from $38 at Piper Sandler
02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
TVTY Tivity Health
$25.85 /

+0.63 (+2.50%)

02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform with $19 target at Credit Suisse
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform from Neutral at Credit Suisse
PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
CTLT Catalent
$102.55 /

+0.76 (+0.75%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
RHHBY Roche
$43.16 /

-0.09 (-0.21%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

03/18/21 Lake Street
Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential
03/18/21 Lake Street
ClearPoint Neuro initiated with a Buy at Lake Street
02/22/21 B. Riley
ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities
01/22/21 B. Riley
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

04/29/21 SVB Leerink
Align Technology price target raised to $770 from $690 at SVB Leerink
04/29/21 Credit Suisse
Align Technology price target raised to $715 from $693 at Credit Suisse
04/29/21 Stifel
Align Technology price target raised to $750 from $650 at Stifel
04/29/21 Baird
Align Technology price target raised to $745 from $655 at Baird
DBTX Decibel Therapeutics
$8.06 /

-0.175 (-2.13%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

TVTY Tivity Health
$25.85 /

+0.63 (+2.50%)

TNDM TNDM
/

+

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

KOD Kodiak Sciences
$81.22 /

+0.81 (+1.01%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

EAR Eargo
$33.22 /

+1.17 (+3.65%)

CUTR Cutera
$38.15 /

-0.17 (-0.44%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BRKR Bruker
$69.74 /

+0.64 (+0.93%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

  • 19
    Feb
  • 12
    Feb
  • 12
    Feb
  • 05
    Feb
  • 28
    Jan
  • 15
    Jan
  • 16
    Dec
  • 11
    Dec
  • 23
    Nov
  • 18
    Nov
  • 11
    Nov
  • 21
    Oct
  • 16
    Oct
  • 17
    Sep
  • 12
    Aug
  • 14
    Aug
  • 23
    Jul
  • 15
    Jul
  • 26
    Jun
  • 11
    Jun
RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

TERN Terns Pharmaceuticals
$15.80 /

-0.11 (-0.69%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

DBTX Decibel Therapeutics
$8.06 /

-0.175 (-2.13%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BRKR Bruker
$69.74 /

+0.64 (+0.93%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

EAR Eargo
$33.22 /

+1.17 (+3.65%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

Conference/Events
UBS to hold a virtual conference » 10:02
05/24/21
05/24
10:02
05/24/21
10:02
NBTX

Nanobiotix

$16.16 /

+ (+0.00%)

, MRNA

Moderna

$164.80 /

+3.245 (+2.01%)

, TELA

Tela Bio

$13.25 /

-0.05 (-0.38%)

, ICLR

Icon

$232.40 /

+1.49 (+0.65%)

, AMWL

Amwell

$11.69 /

-0.01 (-0.09%)

, BRKR

Bruker

$69.47 /

+0.37 (+0.54%)

, SIOX

Sio Gene Therapies

$2.19 /

-0.015 (-0.68%)

, BMRN

BioMarin

$78.16 /

+0.04 (+0.05%)

, NVS

Novartis

$88.27 /

+0.205 (+0.23%)

, TERN

Terns Pharmaceuticals

$15.89 /

-0.02 (-0.13%)

, EAR

Eargo

$32.32 /

+0.27 (+0.84%)

, JAZZ

Jazz Pharmaceuticals

$180.90 /

+0.94 (+0.52%)

, TNDM

TNDM

/

+

, BAYRY

Bayer

$17.03 /

+0.065 (+0.38%)

, ANIK

Anika Therapeutics

$44.01 /

+ (+0.00%)

, CVAC

CureVac

$117.23 /

+1.99 (+1.73%)

, BSX

Boston Scientific

$42.27 /

+0.17 (+0.40%)

, APLT

Applied Therapeutics

$17.22 /

-0.03 (-0.17%)

, ARVN

Arvinas

$66.28 /

-0.19 (-0.29%)

, PACB

Pacific Biosciences

$26.66 /

+1.08 (+4.22%)

, ABBV

AbbVie

$115.99 /

-0.12 (-0.10%)

, ZYXI

Zynex

$15.03 /

+0.23 (+1.55%)

, BAX

Baxter

$82.93 /

-0.13 (-0.16%)

, KOD

Kodiak Sciences

$80.94 /

+0.53 (+0.66%)

, ARWR

Arrowhead

$75.00 /

+0.87 (+1.17%)

, CUTR

Cutera

$38.64 /

+0.32 (+0.84%)

, TVTY

Tivity Health

$25.26 /

+0.04 (+0.16%)

, PTCT

PTC Therapeutics

$39.80 /

+0.32 (+0.81%)

, CTLT

Catalent

$101.85 /

+0.06 (+0.06%)

, RHHBY

Roche

$43.25 /

+0.32 (+0.75%)

, CLPT

ClearPoint Neuro

$18.55 /

-0.12 (-0.64%)

, BNTX

BioNTech

$199.00 /

+3.45 (+1.76%)

, ALGN

Align Technology

$601.02 /

+9.54 (+1.61%)

, DBTX

Decibel Therapeutics

$8.08 /

-0.15 (-1.82%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link

ShowHide Related Items >><<
ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

TVTY Tivity Health
$25.26 /

+0.04 (+0.16%)

TNDM TNDM
/

+

TERN Terns Pharmaceuticals
$15.89 /

-0.02 (-0.13%)

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

KOD Kodiak Sciences
$80.94 /

+0.53 (+0.66%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

DBTX Decibel Therapeutics
$8.08 /

-0.15 (-1.82%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CUTR Cutera
$38.64 /

+0.32 (+0.84%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BRKR Bruker
$69.47 /

+0.37 (+0.54%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
MRNA Moderna
$164.80 /

+3.245 (+2.01%)

05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
ICLR Icon
$232.40 /

+1.49 (+0.65%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
AMWL Amwell
$11.69 /

-0.01 (-0.09%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
BRKR Bruker
$69.47 /

+0.37 (+0.54%)

05/06/21 BTIG
Bruker price target raised to $80 from $73 at BTIG
05/06/21 SVB Leerink
Bruker price target raised to $80 from $70 at SVB Leerink
02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

04/30/21 Wedbush
BioMarin's Q1 revenue was better than expected, says Wedbush
04/26/21 Credit Suisse
BioMarin assumed with an Outperform at Credit Suisse
03/04/21 Guggenheim
BioMarin assumed at Buy from Neutral at Guggenheim
03/01/21 Evercore ISI
BioMarin upgraded to Outperform from In Line at Evercore ISI
NVS Novartis
$88.27 /

+0.205 (+0.23%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
TERN Terns Pharmaceuticals
$15.89 /

-0.02 (-0.13%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
EAR Eargo
$32.32 /

+0.27 (+0.84%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
TNDM TNDM
/

+

05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
05/06/21 Piper Sandler
Tandem Diabetes remains a 'name to buy' after Q1 beat, says Piper Sandler
03/12/21 Piper Sandler
Tandem Diabetes competition concerns overblown, says Piper Sandler
BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
ANIK Anika Therapeutics
$44.01 /

+ (+0.00%)

12/16/20 Barrington
Anika Therapeutics upgraded to Outperform with $43 target at Barrington
12/16/20 Barrington
Anika Therapeutics upgraded to Outperform from Market Perform at Barrington
CVAC CureVac
$117.23 /

+1.99 (+1.73%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
04/29/21 Canaccord
Boston Scientific price target raised to $49 from $44 at Canaccord
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley
Zynex downgraded to Neutral from Buy at B. Riley Securities
BAX Baxter
$82.93 /

-0.13 (-0.16%)

04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
03/26/21 JPMorgan
Baxter a 'stock to own' into earnings and beyond, says JPMorgan
03/22/21 Benchmark
Omnicell price target raised to $155 from $140 at Benchmark
KOD Kodiak Sciences
$80.94 /

+0.53 (+0.66%)

05/11/21 Roth Capital
Roth Capital upgrades Kodiak Sciences to Buy on recent selloff
05/11/21 Roth Capital
Kodiak Sciences upgraded to Buy from Neutral at Roth Capital
05/11/21 BMO Capital
Kodiak Sciences price target lowered to $104 from $138 at BMO Capital
05/11/21 Barclays
Kodiak Sciences price target lowered to $86 from $90 at Barclays
ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

02/08/21 B. Riley
Arrowhead price target raised to $106 from $98 at B. Riley Securities
02/08/21 Citi
Arrowhead price target raised to $110 from $90 at Citi
02/05/21 Chardan
Arrowhead price target raised to $97 from $81 at Chardan
02/05/21 H.C. Wainwright
Arrowhead price target raised to $95 from $90 at H.C. Wainwright
CUTR Cutera
$38.64 /

+0.32 (+0.84%)

03/05/21 Piper Sandler
Cutera price target raised to $42 from $38 at Piper Sandler
02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
TVTY Tivity Health
$25.26 /

+0.04 (+0.16%)

02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform with $19 target at Credit Suisse
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform from Neutral at Credit Suisse
PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
CTLT Catalent
$101.85 /

+0.06 (+0.06%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
RHHBY Roche
$43.25 /

+0.32 (+0.75%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

03/18/21 Lake Street
Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential
03/18/21 Lake Street
ClearPoint Neuro initiated with a Buy at Lake Street
02/22/21 B. Riley
ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities
01/22/21 B. Riley
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

04/29/21 SVB Leerink
Align Technology price target raised to $770 from $690 at SVB Leerink
04/29/21 Credit Suisse
Align Technology price target raised to $715 from $693 at Credit Suisse
04/29/21 Stifel
Align Technology price target raised to $750 from $650 at Stifel
04/29/21 Baird
Align Technology price target raised to $745 from $655 at Baird
DBTX Decibel Therapeutics
$8.08 /

-0.15 (-1.82%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

TVTY Tivity Health
$25.26 /

+0.04 (+0.16%)

TNDM TNDM
/

+

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

KOD Kodiak Sciences
$80.94 /

+0.53 (+0.66%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

EAR Eargo
$32.32 /

+0.27 (+0.84%)

CUTR Cutera
$38.64 /

+0.32 (+0.84%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BRKR Bruker
$69.47 /

+0.37 (+0.54%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

  • 19
    Feb
  • 12
    Feb
  • 12
    Feb
  • 05
    Feb
  • 28
    Jan
  • 15
    Jan
  • 16
    Dec
  • 11
    Dec
  • 23
    Nov
  • 18
    Nov
  • 11
    Nov
  • 21
    Oct
  • 16
    Oct
  • 17
    Sep
  • 12
    Aug
  • 14
    Aug
  • 23
    Jul
  • 15
    Jul
  • 26
    Jun
  • 11
    Jun
RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

TERN Terns Pharmaceuticals
$15.89 /

-0.02 (-0.13%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

DBTX Decibel Therapeutics
$8.08 /

-0.15 (-1.82%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BRKR Bruker
$69.47 /

+0.37 (+0.54%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

EAR Eargo
$32.32 /

+0.27 (+0.84%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

Over a month ago
Recommendations
Eargo price target lowered to $52 from $68 at Wells Fargo » 07:59
05/13/21
05/13
07:59
05/13/21
07:59
EAR

Eargo

$39.01 /

+0.83 (+2.17%)

Wells Fargo analyst…

Wells Fargo analyst Lawrence Biegelsen lowered the firm's price target on Eargo to $52 from $68 to reflect the recent reduction in the peer group multiple, while keeping an Overweight rating on the shares. The analyst notes the company reported a Q1 beat and raised the low-end of its 2021 revenue guidance.

ShowHide Related Items >><<
EAR Eargo
$39.01 /

+0.83 (+2.17%)

05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
EAR Eargo
$39.01 /

+0.83 (+2.17%)

  • 16
    Oct
EAR Eargo
$39.01 /

+0.83 (+2.17%)

EAR Eargo
$39.01 /

+0.83 (+2.17%)

Recommendations
JPMorgan sees four 'compelling' MedTech opportunities after selloff » 07:22
05/12/21
05/12
07:22
05/12/21
07:22
DXCM

DexCom

$347.72 /

+5.08 (+1.48%)

, INSP

Inspire Medical

$179.41 /

-1.01 (-0.56%)

, PODD

Insulet

$230.03 /

+3.1 (+1.37%)

, EAR

Eargo

$38.22 /

+1.54 (+4.20%)

With several…

With several "quality growth names" in medical technology at "more approachable valuation levels" following the recent selloff, there are stocks at "highly attractive entry points," JPMorgan analyst Robbie Marcus tells investors in a research note. The analyst views investor reactions to recent quarters from DexCom (DXCM), Inspire Medical (INSP) and Insulet (PODD) as "clearly overdone," and notes that with Eargo (EAR) is another name that has sold off ahead of its own earnings report later today. All four companies are "fundamentally strong, multi-year growth stocks" that offer an attractive short-term trade potential on a market rebound and "compelling" multi-year investment opportunities, says Marcus.

ShowHide Related Items >><<
PODD Insulet
$230.03 /

+3.1 (+1.37%)

INSP Inspire Medical
$179.41 /

-1.01 (-0.56%)

DXCM DexCom
$347.72 /

+5.08 (+1.48%)

DXCM DexCom
$347.72 /

+5.08 (+1.48%)

04/30/21 Canaccord
DexCom price target raised to $455 from $445 at Canaccord
04/30/21 Citi
DexCom price target raised to $488 from $480 at Citi
04/30/21 Piper Sandler
DexCom should be bought on any share weakness, says Piper Sandler
04/15/21 Atlantic Equities
Atlantic Equities starts DexCom at Overweight
INSP Inspire Medical
$179.41 /

-1.01 (-0.56%)

05/06/21 Piper Sandler
Inspire Medical pullback brings attractive entry point, says Piper Sandler
05/05/21 Lake Street
Inspire Medical price target raised to $260 from $250 at Lake Street
05/05/21 Piper Sandler
Inspire Medical price target raised to $255 from $252 at Piper Sandler
02/24/21 Lake Street
Inspire Medical price target raised to $250 from $215 at Lake Street
PODD Insulet
$230.03 /

+3.1 (+1.37%)

05/07/21 Piper Sandler
Insulet price target lowered to $250 from $260 at Piper Sandler
04/01/21 SVB Leerink
Insulet upgraded to Outperform after diabetes deep dive at SVB Leerink
04/01/21 SVB Leerink
Insulet upgraded to Outperform from Market Perform at SVB Leerink
03/19/21 Canaccord
Canaccord upgrades Insulet to Buy ahead of Omnipod5 launch
EAR Eargo
$38.22 /

+1.54 (+4.20%)

01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
11/10/20 William Blair
Eargo initiated with an Outperform at William Blair
PODD Insulet
$230.03 /

+3.1 (+1.37%)

INSP Inspire Medical
$179.41 /

-1.01 (-0.56%)

EAR Eargo
$38.22 /

+1.54 (+4.20%)

DXCM DexCom
$347.72 /

+5.08 (+1.48%)

  • 16
    Oct
  • 13
    May
DXCM DexCom
$347.72 /

+5.08 (+1.48%)

PODD Insulet
$230.03 /

+3.1 (+1.37%)

INSP Inspire Medical
$179.41 /

-1.01 (-0.56%)

EAR Eargo
$38.22 /

+1.54 (+4.20%)

DXCM DexCom
$347.72 /

+5.08 (+1.48%)

EAR Eargo
$38.22 /

+1.54 (+4.20%)

Over a quarter ago
Earnings
Eargo sees FY21 revenue $87M-$93M, consensus $87.73M » 16:21
02/25/21
02/25
16:21
02/25/21
16:21
EAR

Eargo

$61.13 /

-3.855 (-5.93%)

Sees FY21 fross margin…

Sees FY21 fross margin 70%-72%.

ShowHide Related Items >><<
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
11/10/20 William Blair
Eargo initiated with an Outperform at William Blair
EAR Eargo
$61.13 /

-3.855 (-5.93%)

  • 16
    Oct
EAR Eargo
$61.13 /

-3.855 (-5.93%)

EAR Eargo
$61.13 /

-3.855 (-5.93%)

Earnings
Eargo reports Q4 EPS (30c), consensus (21c) » 16:19
02/25/21
02/25
16:19
02/25/21
16:19
EAR

Eargo

$61.13 /

-3.855 (-5.93%)

Reports Q4 revenue…

Reports Q4 revenue $22.38M, consensus $20.03M. Christian Gormsen, president and CEO, said, "Our momentum through 2020 continued to accelerate in the fourth quarter with net revenue growth above 110% year over year. This growth was driven by strong performance of our national advertising, better than expected sales to customers with insurance coverage, and robust consumer demand during the holiday buying season."

ShowHide Related Items >><<
EAR Eargo
$61.13 /

-3.855 (-5.93%)

01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
11/10/20 William Blair
Eargo initiated with an Outperform at William Blair
EAR Eargo
$61.13 /

-3.855 (-5.93%)

  • 16
    Oct
EAR Eargo
$61.13 /

-3.855 (-5.93%)

EAR Eargo
$61.13 /

-3.855 (-5.93%)

Options
Five new option listings on January 20th » 08:30
01/20/21
01/20
08:30
01/20/21
08:30
AFRM

Affirm

$110.53 /

-6.195 (-5.31%)

, EAR

Eargo

$54.83 /

+0.04 (+0.07%)

, ORIC

Oric Pharmaceuticals

$36.84 /

+0.79 (+2.19%)

, RLAY

Relay Therapeutics

$53.59 /

+8.79 (+19.62%)

New option listings for…

New option listings for January 20th include Affirm Holdings Inc (Class A Stock) (AFRM), Eargo Inc (EAR), Global X FinTech Thematic (FINX), Oric Pharmaceuticals Inc (ORIC), and Relay Therapeutics Inc (RLAY).

ShowHide Related Items >><<
RLAY Relay Therapeutics
$53.59 /

+8.79 (+19.62%)

ORIC Oric Pharmaceuticals
$36.84 /

+0.79 (+2.19%)

AFRM Affirm
$110.53 /

-6.195 (-5.31%)

AFRM Affirm
$110.53 /

-6.195 (-5.31%)

EAR Eargo
$54.83 /

+0.04 (+0.07%)

01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
11/10/20 William Blair
Eargo initiated with an Outperform at William Blair
ORIC Oric Pharmaceuticals
$36.84 /

+0.79 (+2.19%)

08/13/20
Fly Intel: Top five analyst initiations
08/13/20 Baird
Baird starts Oric Pharmaceuticals at Outperform with $45 price target
08/12/20 Baird
Oric Pharmaceuticals initiated with an Outperform at Baird
08/06/20 Citi
Oric Pharmaceuticals upgraded to Buy on valuation at Citi
RLAY Relay Therapeutics
$53.59 /

+8.79 (+19.62%)

12/15/20 H.C. Wainwright
Relay Therapeutics price target raised to $57 from $54 at H.C. Wainwright
12/08/20 JMP Securities
Relay Therapeutics initiated with an Outperform at JMP Securities
11/05/20
Fly Intel: Top five analyst initiations
11/05/20 H.C. Wainwright
Relay Therapeutics initiated with a Buy at H.C. Wainwright
RLAY Relay Therapeutics
$53.59 /

+8.79 (+19.62%)

ORIC Oric Pharmaceuticals
$36.84 /

+0.79 (+2.19%)

EAR Eargo
$54.83 /

+0.04 (+0.07%)

  • 13
    Jan
  • 13
    Nov
  • 16
    Oct
  • 16
    Jul
  • 24
    Apr
AFRM Affirm
$110.53 /

-6.195 (-5.31%)

EAR Eargo
$54.83 /

+0.04 (+0.07%)

AFRM Affirm
$110.53 /

-6.195 (-5.31%)

Recommendations
Eargo price target raised to $60 from $53 at Wells Fargo » 08:13
01/13/21
01/13
08:13
01/13/21
08:13
EAR

Eargo

$53.92 /

+3.17 (+6.25%)

Wells Fargo analyst…

Wells Fargo analyst Lawrence Biegelsen raised the firm's price target on Eargo to $60 from $53 and keeps an Overweight rating on the shares after hosting a meeting with the senior management. The analyst highlights the Eargo5 launch, which is expected to drive significant repeat customer volume and will be an important contributor in driving gross margins from 70% in Q3 to mid-70s over the next few quarters. He also notes that the company is focused on bringing more users from the sidelines to use hearing aids given the significantly underpenetrated nature of the industry. Eargo sees no major barriers for the continued adoption of its technology ahead either from a product or regulatory standpoint, Biegelsen contends, adding that it has strong business momentum entering 2021 as it exited Q4 with record quarterly sales aided by robust hearing aid shipments amid accelerating COVID headwinds. Furthermore, the analyst believes Eargo has future growth opportunities with omni-channel and international.

ShowHide Related Items >><<
EAR Eargo
$53.92 /

+3.17 (+6.25%)

11/10/20
Fly Intel: Top five analyst initiations
11/10/20 JPMorgan
Eargo initiated with an Overweight at JPMorgan
11/10/20 William Blair
Eargo initiated with an Outperform at William Blair
11/10/20 Wells Fargo
Eargo initiated with an Overweight at Wells Fargo
EAR Eargo
$53.92 /

+3.17 (+6.25%)

  • 16
    Oct
EAR Eargo
$53.92 /

+3.17 (+6.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.